QuiVad
My list

Home / Funds / Davidson Kempner European Partners, LLP

Davidson Kempner European Partners, LLP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Evonik Industries AGGermany1.06%September 7, 2026
Elekta AB (publ)Sweden0.99%September 2, 2026
SolvayBelgium0.69%April 13, 2026
Air France-KLMFrance0.65%September 21, 2026
VusionGroupFrance0.59%September 22, 2026
Colonial SFL, Socimi, S.A.Spain0.50%September 8, 2026

Follow by RSS

Get the moves on Davidson Kempner European Partners, LLP by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

506 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
November 30, 2023Novozymes A/SDenmark6.62%November 30, 2023
November 30, 2023EmeisFrance0.00%December 4, 2023
November 30, 2023OrpeaFrance0.00%December 4, 2023
November 29, 2023Novozymes A/SDenmark6.70%November 29, 2023
November 28, 2023Smurfit Kappa Group PLCIreland0.02%
November 24, 2023Smurfit Kappa Group PLCIreland0.02%
November 22, 2023EmeisFrance0.65%December 4, 2023
November 22, 2023OrpeaFrance0.65%December 4, 2023
November 20, 2023Smurfit Kappa Group PLCIreland0.01%
November 16, 2023Novozymes A/SDenmark6.62%November 16, 2023
November 13, 2023Novozymes A/SDenmark6.51%November 13, 2023
November 13, 2023EmeisFrance0.00%November 15, 2023
November 13, 2023OrpeaFrance0.00%November 15, 2023
November 6, 2023Smurfit Kappa Group PLCIreland0.01%
November 1, 2023Novozymes A/SDenmark6.40%November 1, 2023
November 1, 2023BE Semiconductor Industries N.V.Netherlands0.80%
October 27, 2023Novozymes A/SDenmark6.31%October 27, 2023
October 26, 2023Novozymes A/SDenmark6.27%October 26, 2023
October 26, 2023Smurfit Kappa Group PLCIreland0.01%
October 24, 2023Novozymes A/SDenmark6.10%October 24, 2023
October 23, 2023Novozymes A/SDenmark6.07%October 23, 2023
October 23, 2023Smurfit Kappa Group PLCIreland0.01%
October 19, 2023Novozymes A/SDenmark5.97%October 19, 2023
October 12, 2023Smurfit Kappa Group PLCIreland0.01%
October 11, 2023Smurfit Kappa Group PLCIreland0.01%
October 10, 2023Novozymes A/SDenmark5.70%October 10, 2023
October 9, 2023Novozymes A/SDenmark5.53%October 9, 2023
October 6, 2023Novozymes A/SDenmark5.41%October 6, 2023
October 6, 2023Smurfit Kappa Group PLCIreland0.01%
October 5, 2023Smurfit Kappa Group PLCIreland0.01%
October 4, 2023Novozymes A/SDenmark5.28%October 4, 2023
October 3, 2023Novozymes A/SDenmark5.10%October 3, 2023
October 3, 2023Smurfit Kappa Group PLCIreland0.01%
October 2, 2023Smurfit Kappa Group PLCIreland0.01%
September 29, 2023Novozymes A/SDenmark4.85%September 29, 2023
September 28, 2023Novozymes A/SDenmark4.69%September 28, 2023
September 25, 2023Novozymes A/SDenmark4.51%September 25, 2023
September 22, 2023Novozymes A/SDenmark4.42%September 22, 2023
September 21, 2023Novozymes A/SDenmark4.01%September 21, 2023
September 19, 2023Novozymes A/SDenmark3.94%September 19, 2023
September 18, 2023Novozymes A/SDenmark3.70%September 18, 2023
September 13, 2023Novozymes A/SDenmark3.43%September 13, 2023
September 12, 2023BE Semiconductor Industries N.V.Netherlands0.78%
September 7, 2023Novozymes A/SDenmark3.32%September 7, 2023
September 5, 2023Novozymes A/SDenmark3.29%September 5, 2023
August 31, 2023Novozymes A/SDenmark3.11%August 31, 2023
August 30, 2023Novozymes A/SDenmark3.04%August 30, 2023
August 23, 2023Novozymes A/SDenmark2.92%August 23, 2023
August 17, 2023Novozymes A/SDenmark2.80%August 17, 2023
August 9, 2023Novozymes A/SDenmark2.68%August 9, 2023

Download 506 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Davidson Kempner European Partners, LLP, data as at September 22, 2026, https://www.quivad.com/detenteur/davidson-kempner-european-partners-llp?page=3